Skip to main content
Top

Current Treatment Options in Oncology

Issue 3/2022

Content (11 Articles)

Radiotherapy Head and Neck Cancer (PL Swiecicki, Section Editor)

Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence

Paul J. Kreinbrink, Luke M. Lewis, Kevin P. Redmond, Vinita Takiar

Radiotherapy Head and Neck Cancer (PL Swiecicki, Section Editor)

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

Charles T. Lee, Thomas J. Galloway

Radiotherapy Head and Neck Cancer (PL Swiecicki, Section Editor)

HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?

James E. Bates, Conor E. Steuer

Cancer Therapy Cardio-oncology (MG Fradley, Section Editor)

Cancer Therapies and Vascular Toxicities

Alexandra Meilhac, Jennifer Cautela, Franck Thuny

Buprenorphine Palliative and Supportive Care (J Hardy, Section Editor)

Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer

Nicole Bates, Jennifer K. Bello, Nosayaba Osazuwa-Peters, Mark D. Sullivan, Jeffrey F. Scherrer

Acute Myeloid Leukemia Leukemia (PH Wiernik, Section Editor)

Which FLT3 Inhibitor for Treatment of AML?

Jayastu Senapati, Tapan Mahendra Kadia

Open Access Lymphoma Lymphoma (JL Muñoz, Section Editor)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)

Yaya Chu, Margaret Lamb, Mitchell S. Cairo, Dean A. Lee

Adenovirus Sarcoma (SH Okuno, Section Editor)

Role of Virus-Directed Therapy in Soft Tissue Sarcoma

Hira Chaudhary, Sandra D’Angelo

Soft Tissue Sarcoma Sarcoma (SH Okuno, Section Editor)

Immunotherapy and Biomarkers in Sarcoma

Thanate Dajsakdipon, Teerada Siripoon, Nuttapong Ngamphaiboon, Touch Ativitavas, Thitiya Dejthevaporn

Open Access Soft Tissue Sarcoma Sarcoma (SH Okuno, Section Editor)

What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?

Bernd Kasper, Lorenzo D’Ambrosio, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine

Cancer Fatigue Correction

Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options

Melissa S.Y. Thong, Cornelis J. F. van Noorden, Karen Steindorf, Volker Arndt

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine